Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide (Q44869208)

7 December 2017

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide (English)

1 reference

7 December 2017

0 references

0 references

0 references

0 references

S J Houser

1

1 reference

7 December 2017

M Eads

series ordinal

2

1 reference

7 December 2017

J P Embrey

series ordinal

3

1 reference

7 December 2017

S P Welch

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

7 December 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

7 December 2017

857

1 reference

7 December 2017

337-342

1 reference

7 December 2017

1-2

1 reference

Endogenous Opioids: Biology and Function

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Dynorphin: Potent analgesic effect in spinal cord of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Opioid peptide processing and receptor selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Pharmacological and biochemical interactions between opioids and cannabinoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

A diminution of delta9-tetrahydrocannabinol modulation of dynorphin A-(1-17) in conjunction with tolerance development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Involvement of spinal kappa opiod receptors in the antagonistic effect of dynorphins on morphine antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Distinguishable effects of intrathecal dynorphins, somatostatin, neurotensin and s-calcitonin on nociception and motor function in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Intracerebroventricular administration of beta-endorphin releases immunoreactive met-enkephalin from the spinal cord in cats, guinea pigs and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Synergistic interactions of endogenous opioids and cannabinoid systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

Clonidine stimulated the release of dynorphin in the spinal cord of the rat: a possible mechanism for its depressor effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901981-8

10.1016/S0006-8993(00)01981-8

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference